InVivoMab anti-human CD8α

The OKT-8 monoclonal antibody reacts with human CD8α. The CD8 antigen is a transmembrane glycoprotein that acts as a co-receptor for the T cell receptor (TCR). Like the TCR, CD8 binds to class I MHC molecules displayed by antigen presenting cells (APC). CD8 is primarily expressed on the surface of cytotoxic T cells, but can also be found on thymocytes, natural killer cells, and some dendritic cell subsets. CD8 most commonly exists as a heterodimer composed of one CD8α and one CD8β chain however, it can also exist as a homodimer composed of two CD8α chains. Both the CD8α and CD8β chains share significant homology to immunoglobulin variable light chains. The molecular weight of each CD8 chain is approximately 34 kDa. The OKT-8 antibody does not block the binding of the anti-human CD8α antibodies RPA-T8 and HIT8a.

產品名稱:InVivoMab anti-human CD8α

反應種屬:human

宿主來源:mouse

實驗應用:in vivo CD8+ T cell depletion in humanized mice

同種型:IgG2a

免疫原:Human CD8α

克隆性:Monoclonal

克隆號:OKT-8

產品濃度:Lot specific,typically between 4-11 mg/ml

保存溫度:Undiluted at 4°C in the dark

運輸溫度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

預期分子量:150 kDa

產品形式:液體

有效期:One year from the date of receipt if stored as recommended

產地:美國

如需購買或咨詢Bioxcell公司的產品，請聯系Bioxcell*代理商欣博盛生物